Fecal Alpha-1-Antitrypsin is not a suitable parameter to predict clinical relapse in quiescent Crohn's disease.

被引：0
|
作者：
Fischbach, W [1 ]
Diegmann, J [1 ]
机构：
[1] Klinikum Aschaffenburg, Dept Med, Aschaffenburg, Germany
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)83973-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3999
引用
收藏
页码：A976 / A976
页数：1
相关论文
共 50 条
  • [31] Individual fecal a1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis
    Becker, K
    Berger, M
    Niederau, C
    Frieling, T
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2309 - 2314
  • [32] QUALITATIVE STUDY OF FECAL ALPHA-1-ANTITRYPSIN IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE AND PATIENTS WITH ILEOSTOMY
    COLOMBEL, JF
    MIZON, C
    CHEKKOURI, N
    BALDUYCK, M
    CHAUSSADE, S
    BECUWE, C
    DEGAND, P
    MIZON, J
    CORTOT, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1991, 15 (04): : 301 - 305
  • [33] USEFULNESS OF FECAL ALPHA-1-ANTITRYPSIN CLEARANCE AND FECAL CONCENTRATION AS EARLY INDICATOR OF POSTOPERATIVE ASYMPTOMATIC RECURRENCE IN CROHNS-DISEASE
    BOIRIVANT, M
    PALLONE, F
    CIACO, A
    LEONI, M
    FAIS, S
    TORSOLI, A
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (03) : 347 - 352
  • [34] Antibodies to 12 predict clinical response to fecal diversion in Crohn's disease
    Spivak, Jacob
    Landers, Carol J.
    Vasiliauskas, Eric A.
    Abreu, Maria T.
    Dubinsky, Marla C.
    Papadakis, Konstantinos A.
    Ippoliti, Andrew
    Targan, Stephan R.
    Fleshner, Phillip R.
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (12) : 1122 - 1130
  • [35] ALPHA-1-ANTITRYPSIN DEFICIENCY AND LIVER-DISEASE - CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT
    HUSSAIN, M
    MIELIVERGANI, G
    MOWAT, AP
    JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (04) : 497 - 511
  • [36] Relevance of M-like alpha-1-antitrypsin deficiency variants associated with liver and/or lung disease.
    Coni, P
    Pilleri, G
    Sanna, G
    Farci, AMG
    Liguori, C
    Falchi, AM
    Faa, G
    HEPATOLOGY, 1998, 28 (04) : 419A - 419A
  • [37] Antibodies to 12 predict clinical response to fecal diversion in Crohn's disease
    Spivak, J
    Targan, SR
    Vasiliauskas, EA
    Abreu, MT
    Papadakis, KA
    Landers, CJ
    Fleshner, P
    GASTROENTEROLOGY, 2004, 126 (04) : A69 - A69
  • [38] The role of alpha-1-antitrypsin in the etiopathogenesis of chronic venous disease: A prospective clinical trial
    Limandal, Husnu Kamil
    Kaygin, Mehmet Ali
    Ozkaya, Alev Lazoglu
    Ozkara, Taha
    Diler, Mevriye Serpil
    Cucen, Hatice Isil
    Yildiz, Ziya
    Ergun, Servet
    Da, Ozgur
    PHLEBOLOGY, 2023, 38 (01) : 16 - 21
  • [39] FECAL LYSOZYME EXCRETION AND ALPHA-1-ANTITRYPSIN CLEARANCE IN THE ASSESSMENT OF DISEASE-ACTIVITY IN INFLAMMATORY BOWEL-DISEASE
    GRAMABOHBOUTH, GE
    BIEMOND, I
    PENA, AS
    WETERMAN, IT
    VERSPAGET, HW
    BROUWER, J
    LAMERS, CBHW
    GUT, 1988, 29 (10) : A1465 - A1465
  • [40] FECAL ALPHA-1-ANTITRYPSIN (ALPHA-1-AT) - A MARKER OF LOCAL VS SYSTEMIC INFLAMMATION IN PEDIATRIC CROHNS-DISEASE (CD)
    HERZOG, D
    DELVIN, E
    SEIDMAN, E
    GASTROENTEROLOGY, 1995, 108 (04) : A833 - A833
12345